Keyphrases
Atrial Fibrillation
83%
Catalonia
66%
COVID-19
66%
Cardiac Implantable Electronic Device
66%
Cardiac Electronic Device Implantation
66%
Spontaneous Calcium Release
66%
Peripheral Blood Mononuclear Cells
66%
Receptor Clusters
66%
Adrenergic Stimulation
66%
Adenosine A2A Receptor (A2AR)
66%
Ryanodine Receptor
66%
Co-activation
66%
RyR2
66%
Device Implantation
58%
Pacemaker
50%
Implantable Defibrillator
50%
A2A Receptor
24%
Cardiopulmonary Bypass Time
22%
Hospital Discharge Outcome
22%
Mitral Surgery
22%
Aortic Cross-clamp Time
22%
Aortic Valve Bioprosthesis
22%
Sutureless Aortic Valve
22%
Receptor Expression
18%
Adenosine
18%
Right Atrium
18%
Confidence Interval
16%
Implantation Rate
16%
COVID-19 Pandemic
16%
Green Fluorescent Protein
16%
Calcium Overload
14%
Sinus Rhythm
12%
Adenosine Deaminase Activity
12%
Pandemic Fear
8%
Primary Prevention
8%
Random Intercept
8%
No Significant Difference
8%
Social Impact
8%
Mixed Models
8%
Cardioverter-defibrillator Implantation
8%
Spain
8%
State of Alarm
8%
Incidence Rate
8%
Secondary Prevention
8%
Monthly Incidence
8%
Non-communicable Diseases
8%
Post-COVID-19 Era
8%
Calcium Dynamics
8%
Confocal Calcium Imaging
8%
Calcium Sparks
8%
Biochemistry, Genetics and Molecular Biology
Atrial Fibrillation
100%
Adrenergic Stimulation
66%
Calcium Transport
66%
Adenosine
66%
Peripheral Blood Mononuclear Cell
66%
Ryanodine Receptor
66%
Green Fluorescent Protein
33%
Cardiac Muscle Cell
16%
Calcium Signaling
16%
Dynamics
16%
Firing Rate
16%
Adenosine Deaminase
11%
Sinus Rhythm
11%
Blood Plasma
11%
Adenosine A2A Receptor
5%
Cardiac Dysrhythmia
5%
Oxidative Stress
5%
